Investigations show Pfizer, Johnson & Johnson paid $12.6 million in bribes to win drug approvals, government contracts
Johnson & Johnson voluntarily disclosed some of the violations and conducted an internal investigation. Without admitting or denying the allegations, the company agreed to pay more than $48 million to settle the case and $21.4 million to resolve parallel DOJ criminal charges, SEC records show.